MeiraGTx Holdings (MGTX) Net Equity Issued and Repurchased (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Net Equity Issued and Repurchased came in at $5.2 million in Q4 2025, up 21.25% YoY from $4.3 million in Q4 2024, and down 5.04% on a QoQ basis from $5.4 million in Q2 2025.
MeiraGTx Holdings (MGTX) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $5.2 million in Q4 2025.
- Quarterly Net Equity Issued and Repurchased rose 21.25% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.1 million (down 74.62% YoY) and the FY2025 annual result came in at $15.1 million, down 74.62% from the prior year.
- Net Equity Issued and Repurchased retreated to $5.2 million in Q4 2025, from $5.4 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $100.0 million in Q4 2023 to a low of -$2.8 million in Q1 2022.
- A 4-year average of $19.1 million and a median of $4.5 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased sank 95.74% — and 2025, when it surged 237.03%.
- Tracing MGTX's Net Equity Issued and Repurchased over 4 years: stood at -$2.8 million in 2022, then soared by 3704.9% to $100.0 million in 2023, then slumped by 95.74% to $4.3 million in 2024, then advanced by 21.25% to $5.2 million in 2025.
- The last three Net Equity Issued and Repurchased figures came in at $5.2 million (Q4 2025), $5.4 million (Q2 2025), and $4.5 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 5.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.16 Mn |
| Dec 31, 2025 | 5.16 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 5.43 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | 51.94 Mn |
| Sep 30, 2024 | 51.94 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Mar 31, 2022 | -2.77 Mn |
| Mar 31, 2022 | -2.77 Mn |
| Dec 31, 2020 | 9.60 Mn |
| Dec 31, 2020 | 9.60 Mn |